INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis
Europe - BIT:1ISRG - US46120E6023 - Common Stock
400.6 EUR
+25.15 (+6.7%)
We assign a fundamental rating of 7 out of 10 to 1ISRG. 1ISRG was compared to 62 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making 1ISRG a very profitable company, without any liquidiy or solvency issues. 1ISRG is valued quite expensively, but it does show have an excellent growth rating. With these ratings, 1ISRG could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
In the past year 1ISRG was profitable.
1ISRG had a positive operating cash flow in the past year.
In the past 5 years 1ISRG has always been profitable.
1ISRG had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
1ISRG has a better Return On Assets (12.93%) than 91.67% of its industry peers.
Looking at the Return On Equity, with a value of 14.61%, 1ISRG belongs to the top of the industry, outperforming 81.67% of the companies in the same industry.
1ISRG's Return On Invested Capital of 10.75% is amongst the best of the industry. 1ISRG outperforms 88.33% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1ISRG is in line with the industry average of 8.76%.
The 3 year average ROIC (10.15%) for 1ISRG is below the current ROIC(10.75%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.93% | ||
| ROE | 14.61% | ||
| ROIC | 10.75% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
1.3 Margins
The Profit Margin of 1ISRG (28.51%) is better than 96.67% of its industry peers.
In the last couple of years the Profit Margin of 1ISRG has declined.
With an excellent Operating Margin value of 28.96%, 1ISRG belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
1ISRG's Operating Margin has declined in the last couple of years.
1ISRG has a better Gross Margin (66.61%) than 73.33% of its industry peers.
1ISRG's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.96% | ||
| PM (TTM) | 28.51% | ||
| GM | 66.61% |
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
1ISRG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for 1ISRG has been increased compared to 1 year ago.
Compared to 5 years ago, 1ISRG has more shares outstanding
1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 45.01 indicates that 1ISRG is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 45.01, 1ISRG belongs to the top of the industry, outperforming 98.33% of the companies in the same industry.
1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 45.01 |
ROIC/WACC1.24
WACC8.66%
2.3 Liquidity
A Current Ratio of 5.17 indicates that 1ISRG has no problem at all paying its short term obligations.
1ISRG's Current ratio of 5.17 is amongst the best of the industry. 1ISRG outperforms 95.00% of its industry peers.
1ISRG has a Quick Ratio of 4.18. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
1ISRG has a Quick ratio of 4.18. This is amongst the best in the industry. 1ISRG outperforms 95.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.17 | ||
| Quick Ratio | 4.18 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 28.12% over the past year.
The Earnings Per Share has been growing by 11.48% on average over the past years. This is quite good.
1ISRG shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.18%.
1ISRG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.27% yearly.
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
3.2 Future
The Earnings Per Share is expected to grow by 14.53% on average over the next years. This is quite good.
The Revenue is expected to grow by 14.89% on average over the next years. This is quite good.
EPS Next Y13.5%
EPS Next 2Y13.63%
EPS Next 3Y14.59%
EPS Next 5Y14.53%
Revenue Next Year19.68%
Revenue Next 2Y17.01%
Revenue Next 3Y16.2%
Revenue Next 5Y14.89%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 54.06 indicates a quite expensive valuation of 1ISRG.
1ISRG's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.89, 1ISRG is valued quite expensively.
A Price/Forward Earnings ratio of 49.15 indicates a quite expensive valuation of 1ISRG.
Based on the Price/Forward Earnings ratio, 1ISRG is valued a bit more expensive than 65.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.99, 1ISRG is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 54.06 | ||
| Fwd PE | 49.15 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ISRG indicates a slightly more expensive valuation: 1ISRG is more expensive than 65.00% of the companies listed in the same industry.
1ISRG's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 83.62 | ||
| EV/EBITDA | 49.41 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
1ISRG has an outstanding profitability rating, which may justify a higher PE ratio.
1ISRG's earnings are expected to grow with 14.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)4
PEG (5Y)4.71
EPS Next 2Y13.63%
EPS Next 3Y14.59%
5. Dividend
5.1 Amount
No dividends for 1ISRG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1ISRG (10/21/2025, 7:00:00 PM)
400.6
+25.15 (+6.7%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.66%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap143.61B
Revenue(TTM)9.61B
Net Income(TTM)2.61B
Analysts79
Price Target513.31 (28.14%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.33%
Min EPS beat(2)3.05%
Max EPS beat(2)11.61%
EPS beat(4)4
Avg EPS beat(4)11.45%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)8.83%
EPS beat(12)11
Avg EPS beat(12)6.4%
EPS beat(16)13
Avg EPS beat(16)4.58%
Revenue beat(2)2
Avg Revenue beat(2)1.47%
Min Revenue beat(2)1.09%
Max Revenue beat(2)1.84%
Revenue beat(4)3
Avg Revenue beat(4)1.98%
Min Revenue beat(4)-0.14%
Max Revenue beat(4)5.12%
Revenue beat(8)4
Avg Revenue beat(8)0.5%
Revenue beat(12)6
Avg Revenue beat(12)0.42%
Revenue beat(16)7
Avg Revenue beat(16)0.13%
PT rev (1m)2.06%
PT rev (3m)0.7%
EPS NQ rev (1m)-0.34%
EPS NQ rev (3m)0%
EPS NY rev (1m)-0.04%
EPS NY rev (3m)4.02%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)0.25%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)1.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 54.06 | ||
| Fwd PE | 49.15 | ||
| P/S | 18.23 | ||
| P/FCF | 83.62 | ||
| P/OCF | 59.01 | ||
| P/B | 9.34 | ||
| P/tB | 9.54 | ||
| EV/EBITDA | 49.41 |
EPS(TTM)7.41
EY1.85%
EPS(NY)8.15
Fwd EY2.03%
FCF(TTM)4.79
FCFY1.2%
OCF(TTM)6.79
OCFY1.69%
SpS21.97
BVpS42.87
TBVpS41.99
PEG (NY)4
PEG (5Y)4.71
Graham Number84.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.93% | ||
| ROE | 14.61% | ||
| ROCE | 14.34% | ||
| ROIC | 10.75% | ||
| ROICexc | 15.26% | ||
| ROICexgc | 15.7% | ||
| OM | 28.96% | ||
| PM (TTM) | 28.51% | ||
| GM | 66.61% | ||
| FCFM | 21.81% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
ROICexc(3y)15.35%
ROICexc(5y)15.85%
ROICexgc(3y)16.06%
ROICexgc(5y)16.75%
ROCE(3y)13.54%
ROCE(5y)13.16%
ROICexgc growth 3Y-7.59%
ROICexgc growth 5Y-7%
ROICexc growth 3Y-6.87%
ROICexc growth 5Y-6.06%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score6
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 144.66% | ||
| Cap/Sales | 9.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 87.68% | ||
| Profit Quality | 76.48% | ||
| Current Ratio | 5.17 | ||
| Quick Ratio | 4.18 | ||
| Altman-Z | 45.01 |
F-Score6
WACC8.66%
ROIC/WACC1.24
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
EPS Next Y13.5%
EPS Next 2Y13.63%
EPS Next 3Y14.59%
EPS Next 5Y14.53%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
Revenue Next Year19.68%
Revenue Next 2Y17.01%
Revenue Next 3Y16.2%
Revenue Next 5Y14.89%
EBIT growth 1Y34.8%
EBIT growth 3Y8.76%
EBIT growth 5Y11.37%
EBIT Next Year40.01%
EBIT Next 3Y23.66%
EBIT Next 5Y20.2%
FCF growth 1Y69.15%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y52.09%
OCF growth 3Y4.95%
OCF growth 5Y8.61%
INTUITIVE SURGICAL INC / 1ISRG.MI FAQ
Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?
ChartMill assigns a fundamental rating of 7 / 10 to 1ISRG.MI.
Can you provide the valuation status for INTUITIVE SURGICAL INC?
ChartMill assigns a valuation rating of 2 / 10 to INTUITIVE SURGICAL INC (1ISRG.MI). This can be considered as Overvalued.
Can you provide the profitability details for INTUITIVE SURGICAL INC?
INTUITIVE SURGICAL INC (1ISRG.MI) has a profitability rating of 8 / 10.
What are the PE and PB ratios of INTUITIVE SURGICAL INC (1ISRG.MI) stock?
The Price/Earnings (PE) ratio for INTUITIVE SURGICAL INC (1ISRG.MI) is 54.06 and the Price/Book (PB) ratio is 9.34.
What is the expected EPS growth for INTUITIVE SURGICAL INC (1ISRG.MI) stock?
The Earnings per Share (EPS) of INTUITIVE SURGICAL INC (1ISRG.MI) is expected to grow by 13.5% in the next year.